Obstructive Sleep Apnea’s Diagnosis Shaken: Night-to-Night Variability Raises Concerns Over Current Standards

Obstructive sleep apnea (OSA), long diagnosed by fixed numerical thresholds in the Apnea-Hypopnea Index (AHI), is proving to be a far more variable condition than previously recognized. Recent research highlights substantial night-to-night fluctuations in AHI, challenging the accuracy and clinical reliability of a single-night sleep lab study and calling for a re-evaluation of diagnostic and treatment protocols.

The Problem With One Night in the Sleep Lab

The cornerstone of OSA diagnosis—the AHI, which counts airway pauses or shallow breathing events per hour of sleep—has been traditionally measured during a single night of in-laboratory polysomnography. This measure decides who gets diagnosed with OSA and who qualifies for continuous positive airway pressure (CPAP) therapy reimbursement worldwide.

However, Professor Jean-Louis Pépin from the University of Grenoble cautions this method’s limits. Because OSA is highly variable, a single night’s test can be misleading. Factors such as changes in body weight, development of heart conditions like atrial fibrillation or heart failure, and even physiological milestones like menopause influence the disease’s expression over time.

Moreover, variability isn’t limited to long-term changes. OSA severity fluctuates significantly from one night to the next. Studies indicate that between 20% and 50% of patients might be misclassified based on one night of data, with more than 11% falsely diagnosed and about 18% of true OSA cases overlooked.¹

Seasonal and Environmental Influences Intensify OSA Burden

Additional factors influence OSA’s severity beyond the patient’s health. A recent study using contactless sensors placed in patients’ beds found that AHI values rose approximately 5% during summer and winter compared to spring and autumn in the Northern Hemisphere. Warmer bedroom temperatures were linked to an AHI increase of over 6%.

This association holds alarming implications: global warming — projected to raise temperatures by 1.8°C or more above pre-industrial levels by 2100 — could drive a 1.2 to 3-fold rise in OSA prevalence worldwide.²

Behavioral Patterns Affect Weekend OSA Severity

Another revealing insight from home-monitoring studies showed that OSA severity tends to peak on Saturdays, especially in men and younger adults. Dubbed “social apnea” by researchers, this pattern reflects the compounded effect of sleep debt from the workweek, leading to longer weekend sleep durations, alongside increased tobacco and alcohol use during weekends.³

Reassessing Diagnostic Thresholds Amid Night-to-Night Fluctuations

Professor Silke Ryan of St. Vincent’s Private Hospital in Dublin calls the fixation on rigid AHI cutoffs “naïve,” noting that the current International Classification of Sleep Disorders guidelines, which the German S3 clinical guideline aligns with, may inadequately capture the true scope of OSA due to variability.

Currently, OSA is diagnosed if:

• AHI ≥ 15 events per hour of sleep, regardless of symptoms
• AHI ≥ 5 events per hour coupled with typical symptoms like daytime sleepiness, partner observations of snoring or breathing pauses, or significant comorbidities

Yet depending on the night, patients’ AHI scores can drift above or below these thresholds, blurring treatment decisions. Ryan argues for personalized diagnostic and therapeutic approaches that integrate clinical context—such as pretest probability, comorbid conditions, risk assessment, and patient preferences—instead of a sole reliance on the AHI.

Technology Offers Hope for More Reliable, Patient-Centered Assessments

While multiple consecutive nights of polysomnography would better capture OSA’s variability, current sleep lab resources are insufficient to accommodate this demand. Ryan highlights emerging contactless sensor technologies deployed in patients’ homes, which correlate reasonably well with standard polysomnography and can reveal nightly variability, particularly in patients with milder forms of OSA.

Though these home devices are not yet standard medical tools, their use is recommended for patients with uncertain OSA probability or when clinical symptoms and single-night sleep lab results do not align, helping avoid misdiagnosis and inappropriate treatment.

Why This Matters for Public Health

Obstructive sleep apnea affects millions globally and is linked to major health risks including cardiovascular disease, stroke, diabetes, and daytime accidents. With climate change and social lifestyle patterns potentially amplifying the burden, refining how we detect and treat OSA is a pressing public health priority.

The variability in OSA severity underscores the need for flexible, patient-focused care models and technological innovation to optimize outcomes and resource use. This shift could advance individualized medicine in sleep health and prevent both overtreatment and undertreatment of this complex condition.